Drug intelligence / Profile preview

bepotastine besilate + fluticasone propionate

Development stage
Unknown
Lead developer
Bausch + Lomb
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Ophthalmic, Intranasal, Inhalation
01

Overview

Bepotastine besilate + fluticasone propionate is a combination of two pharmaceutical agents used for the treatment of allergic conditions, particularly allergic rhinitis. Bepotastine besilate is a second-generation non-sedative antihistamine that acts as a Histamine H1 receptor (H1R) antagonist, blocking the effects of histamine and thereby reducing symptoms such as itching and sneezing[4][5]. Fluticasone propionate is a synthetic corticosteroid that reduces inflammation by inhibiting multiple types of inflammatory cells and decreasing the production of mediators involved in allergic responses[3][6]. While both drugs are individually approved for use in various forms (ophthalmic solution for bepotastine; nasal spray or inhaler for fluticasone), there is no widely marketed fixed-dose combination product containing both agents together. However, clinical trials have evaluated their combined use in treating seasonal allergic rhinitis[2].

Brand names
Arnuity Ellipta
02

Targets

GR (Glucocorticoid receptor)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on bepotastine besilate + fluticasone propionate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bepotastine besilate + fluticasone propionate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call